FI941259A - Uudet alfa-mannosidaasiestäjät - Google Patents

Uudet alfa-mannosidaasiestäjät Download PDF

Info

Publication number
FI941259A
FI941259A FI941259A FI941259A FI941259A FI 941259 A FI941259 A FI 941259A FI 941259 A FI941259 A FI 941259A FI 941259 A FI941259 A FI 941259A FI 941259 A FI941259 A FI 941259A
Authority
FI
Finland
Prior art keywords
alpha
beta
new alpha
mannosidase inhibitors
mannosidase
Prior art date
Application number
FI941259A
Other languages
English (en)
Swedish (sv)
Other versions
FI941259A0 (fi
FI105270B (fi
Inventor
Robert A Farr
Mohinder S Kang
Norton P Peet
Sai P Sunkara
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI941259A0 publication Critical patent/FI941259A0/fi
Publication of FI941259A publication Critical patent/FI941259A/fi
Application granted granted Critical
Publication of FI105270B publication Critical patent/FI105270B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
FI941259A 1991-09-18 1994-03-17 Menetelmä terapeuttisesti käyttökelpoisten oktahydro-1H-1-pyrindiini-4,5,6,7-terolien valmistamiseksi FI105270B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US76157991A 1991-09-18 1991-09-18
US76157991 1991-09-18
US07/893,171 US5262425A (en) 1991-09-18 1992-06-03 α-mannosidase inhibitors
US89317192 1992-06-03
US9206707 1992-08-10
PCT/US1992/006707 WO1993005781A1 (en) 1991-09-18 1992-08-10 Novel alpha-mannosidase inhibitors

Publications (3)

Publication Number Publication Date
FI941259A0 FI941259A0 (fi) 1994-03-17
FI941259A true FI941259A (fi) 1994-03-17
FI105270B FI105270B (fi) 2000-07-14

Family

ID=27117010

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941259A FI105270B (fi) 1991-09-18 1994-03-17 Menetelmä terapeuttisesti käyttökelpoisten oktahydro-1H-1-pyrindiini-4,5,6,7-terolien valmistamiseksi

Country Status (15)

Country Link
US (1) US5262425A (fi)
EP (1) EP0641327B1 (fi)
JP (1) JP3226173B2 (fi)
KR (1) KR100244012B1 (fi)
AT (1) ATE175960T1 (fi)
AU (1) AU659486B2 (fi)
CA (1) CA2116224C (fi)
DE (1) DE69228259T2 (fi)
DK (1) DK0641327T3 (fi)
ES (1) ES2127758T3 (fi)
FI (1) FI105270B (fi)
GR (1) GR3029745T3 (fi)
HU (1) HU216789B (fi)
NO (1) NO300372B1 (fi)
WO (1) WO1993005781A1 (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
US6048870A (en) * 1996-10-01 2000-04-11 Glycodesign 3, 5, and/or 6 substituted analogues of swainsonine processes for their preparation and their use as therapeutic agents
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
US6245316B1 (en) 1997-10-08 2001-06-12 David Platt Enhancement of delivery of radioimaging and radioprotective agents
EP1023290A1 (en) * 1997-10-24 2000-08-02 Glycodesign Inc. Synthesis of swainsonine salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031102A (en) * 1972-10-21 1977-06-21 John Wyeth & Brother Limited Cyclopenteno[b]pyridine derivatives
GB2088860B (en) * 1980-12-09 1984-05-23 Wyeth John & Brother Ltd Process for preparing ring-fused pyridine derivatives

Also Published As

Publication number Publication date
AU2477192A (en) 1993-04-27
FI941259A0 (fi) 1994-03-17
DE69228259T2 (de) 1999-06-02
US5262425A (en) 1993-11-16
HU9400787D0 (en) 1994-06-28
EP0641327A1 (en) 1995-03-08
GR3029745T3 (en) 1999-06-30
EP0641327B1 (en) 1999-01-20
NO940972L (no) 1994-03-17
NO300372B1 (no) 1997-05-20
DE69228259D1 (de) 1999-03-04
CA2116224C (en) 2003-06-03
ATE175960T1 (de) 1999-02-15
AU659486B2 (en) 1995-05-18
DK0641327T3 (da) 1999-09-13
EP0641327A4 (en) 1994-06-01
ES2127758T3 (es) 1999-05-01
JPH06510785A (ja) 1994-12-01
HUT70527A (en) 1995-10-30
JP3226173B2 (ja) 2001-11-05
KR100244012B1 (ko) 2000-03-02
CA2116224A1 (en) 1993-04-01
WO1993005781A1 (en) 1993-04-01
HU216789B (hu) 1999-08-30
NO940972D0 (no) 1994-03-17
FI105270B (fi) 2000-07-14

Similar Documents

Publication Publication Date Title
NO944430D0 (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
BR9203707A (pt) Compostos,composicao,emprego de compostos,processo para a fotopolimerizacao de compostos e emprego de uma composicao
CO4290353A1 (es) Agonistas de estrogeno
DK0563345T3 (da) Nye 4-arylpiperaziner og 4-arylpiperidiner
ES2148229T3 (es) Eteres y tioeteres en la posicion 17 de 4-aza-esteroides.
DE69516866D1 (de) Stereochemische wortmanninderivate
DK0386997T3 (da) Anvendelse af 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater i behandlingen af psykose, inflammation og som immunosuppressive midler
DE69115280D1 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
KR950704257A (ko) 매트릭스 메탈로프로테이나제 억제제로서의 카보스티릴 유도체(Carbostyril derivatives as matrix metalloproteinases inhibitors)
FI941259A (fi) Uudet alfa-mannosidaasiestäjät
SE9600120D0 (sv) Novel medical use
ES2034678T3 (es) Procedimiento para aumentar la productividad de los cerdos.
PA7801701A1 (es) Compuestos ariltios
HU911196D0 (en) Alpha-mannosidaze and functosidaze inhibitors
ES2060405T3 (es) Derivado de la melatonina que tiene actividad terapeutica en dermatologia.
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
PT94011A (pt) Processo para a preparacao de 8 alfa- acilamino-ergolinas e de composicoes farmaceuticas que as contem
PT98268A (pt) Processo para a preparacao de indano-pirrolidino-carbamatos
MX9305453A (es) Metodo para tratar infecciones virales.
FI922016A0 (fi) Foerfarande foer framstaellning av dubbelskyddade 1-karba(1-detia)-3-kefem-4-karboxylsyror.
ITRM940151A0 (it) Impiego di esteruretani per la riconcia.
PL292747A1 (en) Method of obtaining novel (-)-trans-4-(2-(n,n-diethylamine) ethoxyl)-cis-crane
IT8921649A0 (it) Processo per la riduzione catalistica di composti carbonilici.
ITMI931684A0 (it) Procedimento per la preparazione di derivati del 5,4- diidrocarbostirile